Exosome Therapy

The basics

What are exosomes?

Exosomes are extracellular vesicles — tiny membrane-bound packages, roughly 30 to 150 nanometers across, released by nearly every cell in the body. For decades they were dismissed as cellular waste disposal. That view has been thoroughly overturned.

Exosomes are now understood as a fundamental communication system between cells. Each one carries a cargo of proteins, lipids, growth factors, and genetic material — messenger RNA and microRNA — from its parent cell to recipient cells, where that cargo can influence behavior.

In regenerative medicine, the exosomes of interest are typically derived from mesenchymal stem cells. If MSCs work largely by signaling, exosomes are a substantial part of how that signaling physically happens.

How they work

The mechanism researchers describe runs in three steps:

• Release. A parent cell packages signaling molecules into a vesicle and releases it into the surrounding environment.
• Travel. The exosome circulates, protected by its membrane, until it reaches a recipient cell.
• Delivery. It fuses with or is absorbed by the recipient cell, delivering its cargo — potentially influencing inflammation, cell survival signaling, and local repair activity.

Because exosomes are cell-derived products rather than living cells, they behave differently from cell therapy in handling, storage, and administration — a distinction physicians weigh when choosing between or combining approaches.

Exosomes vs. MSC therapy

These are related but not interchangeable. MSC therapy administers living cells that then produce signals over time. Exosome therapy administers the signaling packages themselves — no living cells involved.

Some physicians use them independently; others combine them within a single protocol. Which makes sense for a given patient is a clinical judgment, made after the medical review.

Potential uses

Areas under active research and clinical exploration include:

• Orthopedic and joint applications, often alongside MSC injections
• Tendon, ligament, and sports-injury recovery support
• Inflammatory and autoimmune conditions
• Neurological research applications
• Aesthetic and dermatologic regenerative protocols
• Hair restoration protocols
• General wellness and recovery programs

The treatment process

A CPRT-coordinated exosome protocol generally follows this arc:

• Medical review — records, imaging, and goals evaluated by the physician team.
• Protocol design — route, dose, and whether exosomes are used alone or with MSC therapy.
• Administration — IV infusion, targeted injection, or topical/aesthetic application depending on the plan. Most administrations are brief outpatient procedures.
• Monitored rest — observation on the hospital campus following administration.
• Follow-up — coordinated check-ins after you return home.

Recovery

Exosome administration is typically low-impact. Most patients return to normal activity quickly — often the same or next day — with any injection-site soreness resolving over a short period. Physicians commonly advise avoiding strenuous activity briefly and staying well hydrated.

As with MSC therapy, any effects are expected to develop gradually rather than immediately, and individual responses vary widely.

The state of research

Exosome research has expanded rapidly over the past decade, spanning regenerative applications, drug delivery, and diagnostics. Clinical trials are ongoing internationally across multiple indications.

What that means practically: there is real scientific substance here, and there is also real uncertainty. CPRT's position is that patients deserve both halves of that sentence. Our role is to connect you with physicians who will discuss the evidence for your specific situation candidly — including when the honest answer is that it isn't a fit.